Both aggregated and soluble tau found in the brain of AD patients show reactivity to antibodies detecting phosphorylated tau, as well as to an antibody reactive for non-phosphorylated tau following alkaline phosphatase digestion [55]. This evidence concerns the gene MAPT and Alzheimer disease.